WALTHAM, Mass., Feb. 1 /PRNewswire-FirstCall/ -- Oscient
Pharmaceuticals Corporation (Nasdaq: OSCI) will release financial results
for the fourth quarter and fiscal year ended December 31, 2007 on
Wednesday, February 6, 2008 prior to the opening of the U.S. financial
markets. A conference call will be held at 8:30 a.m. Eastern Time with
Steven Rauscher, President and CEO, and other members of Oscient's
management team. The Company announced preliminary revenue results of
approximately $80 million for fiscal year 2007 on January 14, 2008.
What: Fourth Quarter and Fiscal Year 2007 Financial Results
When: February 6, 2008 at 8:30 am Eastern Time
How: Domestic participants can access the call by dialing
1-888-634-4009.
International participants are asked to dial 1-706-634-5451. The call
will also be webcast through the Company's website at
Contact: Christopher Taylor, 781-398-2466 or Sarah Emond, 781-398-2544
A replay will be available two hours after the conclusion of the call until February 13, 2008. Domestic participants can access the replay by dialing 1-800-642-1687, while international participants are asked to dial 1-706-645-9291. The conference ID number for the replay is 33514080. A replay will also be available through http://www.oscient.com.
About Oscient Pharmaceuticals
Oscient Pharmaceuticals Corporation is a commercial-stage
pharmaceutical company marketing two FDA-approved products in the United
States; ANTARA(R) (fenofibrate) capsules, a cardiovascular product and
FACTIVE(R) (gemifloxacin mesylate) t
'/>"/>
| SOURCE Oscient Pharmaceuticals Corporation Copyright©2008 PR Newswire. All rights reserved |